VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,917 | -29.1% | 2,105,298 | +0.2% | 0.02% | -25.9% |
Q2 2023 | $39,401 | +36.2% | 2,101,361 | +4.7% | 0.03% | +28.6% |
Q1 2023 | $28,929 | -16.9% | 2,006,127 | +11.5% | 0.02% | -22.2% |
Q4 2022 | $34,824 | -99.9% | 1,799,650 | +43.4% | 0.03% | -20.6% |
Q3 2022 | $43,103,000 | – | 1,254,816 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,008,809 | $26,636,807 | 17.30% |
Alphabet Inc. | 10,549,086 | $139,880,880 | 8.98% |
Casdin Capital, LLC | 2,954,710 | $39,179,455 | 4.34% |
MPM BioImpact LLC | 857,940 | $11,376,284 | 3.04% |
Saltoro Capital, LP | 66,500 | $881,790 | 0.79% |
ARK Investment Management | 5,200,567 | $68,959,525 | 0.53% |
Redmile Group, LLC | 809,777 | $10,737,643 | 0.51% |
Ikarian Capital, LLC | 2,413 | $3,199,638 | 0.38% |
Logos Global Management LP | 215,000 | $2,850,900 | 0.38% |
Nikko Asset Management Americas, Inc. | 2,147,243 | $28,429,497 | 0.34% |